Zydus Lifesciences receives final approval from US FDA for Cyanocobalamin injection The injection is used to treat and prevent lack of vitamin B12 that may be caused due to pernicious anaemia, certain diseases, infections or medications decrease the amount of vitamin B12 absorbed from food Zydus Lifesciences has received final approval from the US Food and Drug Administrration (FDA) to market Cyanocobalamin injection in the strengths of 1,000 mcg/mL,10,000 mcg/10 mL (1,000 mcg/mL), and 30,000 mcg/30 mL (1,000 mcg/mL) multiple-dose vials, a company statement said
Engaging in regular physical activity and adhering to a healthy diet can enhance the medications effects, particularly regarding weight loss
For weight management, NHS use follows specific NICE technology appraisals (such as TA875 for semaglutide and TA664 for liraglutide) and typically requires specialist service involvement
Notify your doctor if symptoms persist or are severe